Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam
· Delayed Price · Currency is VND 20,400
-2,100 (-9.33%)
At close: Jan 30, 2026
HNX:MED Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 24,401 | 42,611 | 43,534 | 81,183 | 46,107 | Upgrade
|
| Short-Term Investments | 6,700 | 12,000 | 20,000 | 92,400 | 48,400 | Upgrade
|
| Cash & Short-Term Investments | 31,101 | 54,611 | 63,534 | 173,583 | 94,507 | Upgrade
|
| Cash Growth | -43.05% | -14.04% | -63.40% | 83.67% | -12.15% | Upgrade
|
| Accounts Receivable | 39,275 | 66,896 | 90,917 | 127,297 | 113,221 | Upgrade
|
| Other Receivables | 187.06 | 4,377 | 2,776 | 12,614 | 20,472 | Upgrade
|
| Receivables | 39,462 | 71,273 | 93,693 | 139,911 | 133,694 | Upgrade
|
| Inventory | 92,808 | 87,540 | 102,920 | 102,221 | 87,933 | Upgrade
|
| Prepaid Expenses | - | 239.81 | 213.21 | 38.92 | 41.71 | Upgrade
|
| Other Current Assets | 40,877 | 39,417 | 40,509 | 42,719 | 25,935 | Upgrade
|
| Total Current Assets | 204,249 | 253,081 | 300,868 | 458,474 | 342,110 | Upgrade
|
| Property, Plant & Equipment | 212,824 | 212,121 | 214,196 | 181,186 | 109,257 | Upgrade
|
| Other Intangible Assets | 11.76 | 19.18 | 26.61 | 34.03 | - | Upgrade
|
| Other Long-Term Assets | 39,663 | 38,534 | 40,152 | 58,793 | 42,271 | Upgrade
|
| Total Assets | 456,747 | 503,755 | 555,243 | 698,487 | 493,638 | Upgrade
|
| Accounts Payable | 55,093 | 77,962 | 74,430 | 84,885 | 41,394 | Upgrade
|
| Accrued Expenses | 18,999 | 14,827 | 15,950 | 14,771 | 8,501 | Upgrade
|
| Short-Term Debt | 33,914 | 27,787 | 64,463 | 90,835 | 68,595 | Upgrade
|
| Current Income Taxes Payable | - | 948.94 | 651.91 | 2,393 | 1,430 | Upgrade
|
| Current Unearned Revenue | 15,436 | 15,994 | 29,637 | - | - | Upgrade
|
| Other Current Liabilities | 2,557 | 35,373 | 42,914 | 183,602 | 207,937 | Upgrade
|
| Total Current Liabilities | 125,998 | 172,892 | 228,046 | 376,486 | 327,857 | Upgrade
|
| Other Long-Term Liabilities | 0 | - | - | - | - | Upgrade
|
| Total Liabilities | 125,998 | 172,892 | 228,046 | 376,486 | 327,857 | Upgrade
|
| Common Stock | 124,100 | 124,100 | 124,100 | 124,100 | 62,801 | Upgrade
|
| Additional Paid-In Capital | 121,230 | 121,230 | 121,230 | 121,230 | 29,425 | Upgrade
|
| Retained Earnings | 85,420 | 85,533 | 81,867 | 76,671 | 73,536 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | 18.33 | Upgrade
|
| Shareholders' Equity | 330,750 | 330,863 | 327,197 | 322,002 | 165,780 | Upgrade
|
| Total Liabilities & Equity | 456,747 | 503,755 | 555,243 | 698,487 | 493,638 | Upgrade
|
| Total Debt | 33,914 | 27,787 | 64,463 | 90,835 | 68,595 | Upgrade
|
| Net Cash (Debt) | -2,813 | 26,824 | -929.58 | 82,748 | 25,912 | Upgrade
|
| Net Cash Growth | - | - | - | 219.34% | -3.94% | Upgrade
|
| Net Cash Per Share | -226.72 | 2161.51 | -74.91 | 8813.28 | 4128.39 | Upgrade
|
| Filing Date Shares Outstanding | 12.41 | 12.41 | 12.43 | 12.41 | 6.28 | Upgrade
|
| Total Common Shares Outstanding | 12.41 | 12.41 | 12.43 | 12.41 | 6.28 | Upgrade
|
| Working Capital | 78,251 | 80,189 | 72,822 | 81,988 | 14,253 | Upgrade
|
| Book Value Per Share | 26651.87 | 26661.01 | 26331.15 | 25946.94 | 26397.75 | Upgrade
|
| Tangible Book Value | 330,738 | 330,844 | 327,170 | 321,968 | 165,780 | Upgrade
|
| Tangible Book Value Per Share | 26650.92 | 26659.47 | 26329.01 | 25944.20 | 26397.75 | Upgrade
|
| Buildings | 47,111 | 47,111 | 47,111 | - | - | Upgrade
|
| Machinery | 111,967 | 107,117 | 105,558 | - | - | Upgrade
|
| Construction In Progress | 180,595 | 177,699 | 173,769 | 130,085 | 67,159 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.